Johnson & Johnson (JNJ) 재무상태표
NYSE · Healthcare · Drug Manufacturers - General · 직원 141,700명 · CEO Joaquin Duato
- 주가
- $273.20 -0.73%
- 시가총액
- $6580억
- 기업가치
- $6850억
- 최근 실적
- Q3 '26 2026-10-21 제출
- 다음 실적
- 2027-01-26 EPS 추정 $2.91
Johnson & Johnson (JNJ)의 Q3 '26말 현금 및 단기투자는 $172억, 리스 포함 차입금은 $447억입니다. 자산총계 $1970억, 부채총계 $1160억, 주주지분 $815억.
재무상태표
| 재무상태표 | 추세 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 자산 | |||||||||||||
| 현금 및 현금성자산 | $219억 | $255억 | $249억 | $200억 | $241억 | $385억 | $186억 | $182억 | $197억 | $217억 | $204억 | $169억 | |
| 단기투자 | $10.7억 | $7.45억 | $5.97억 | $3.17억 | $4.17억 | $3.07억 | $3.03억 | $3.31억 | $3.93억 | $3.63억 | $3.36억 | $3.18억 | |
| 매출채권 | $194억 | $149억 | $158억 | $162억 | $189억 | $160억 | $178억 | $176억 | $172억 | $177억 | $190억 | $190억 | |
| 재고자산 | $112억 | $114억 | $122억 | $126억 | $124억 | $127억 | $134억 | $141억 | $142억 | $146억 | $151억 | $154억 | |
| 기타 유동자산 | $0 | $44.6억 | $43.8억 | $41.8억 | $0 | $40.9억 | $43.6억 | $42.9억 | $41.5억 | $48.2억 | $0 | $47.6억 | |
| 유동자산 | $535억 | $570억 | $578억 | $532억 | $559억 | $716억 | $545억 | $546억 | $556억 | $592억 | $598억 | $564억 | |
| 유형자산(순액) | $199억 | $196억 | $197억 | $205억 | $205억 | $209억 | $219억 | $534억 | $232억 | $547억 | $236억 | $241억 | |
| 영업권 | $366억 | $366억 | $443억 | $448억 | $442억 | $445억 | $481억 | $480억 | $488억 | $486억 | $485억 | $485억 | |
| 무형자산 | $342억 | $343억 | $397억 | $395억 | $376억 | $368억 | $498억 | $487억 | $504억 | $491억 | $482억 | $467억 | |
| 이연법인세자산 | $92.8억 | $103억 | $90억 | $93.5억 | $105억 | $84.9억 | $68억 | $66.7억 | $68.7억 | $67.3억 | $67.3억 | $67.5억 | |
| 기타 비유동자산 | $142억 | $141억 | $105억 | $109억 | $114억 | $115억 | $122억 | -$186억 | $144억 | -$173억 | $143억 | $151억 | |
| 비유동자산 | $1140억 | $1150억 | $1230억 | $1250억 | $1240억 | $1220억 | $1390억 | $1380억 | $1440억 | $1420억 | $1410억 | $1410억 | |
| 자산총계 | $1680억 | $1720억 | $1810억 | $1780억 | $1800억 | $1940억 | $1930억 | $1930억 | $1990억 | $2010억 | $2010억 | $1970억 | |
| 부채 | |||||||||||||
| 매입채무 | $96.3억 | $81.7억 | $88.5억 | $89.5억 | $103억 | $95.5억 | $94.6억 | $96.3억 | $120억 | $105억 | $92.2억 | $93.2억 | |
| 미지급비용 | $262억 | $265억 | $281억 | $299억 | $261억 | $267억 | $282억 | $290억 | $277억 | $258억 | $328억 | $353억 | |
| 단기차입금 | $34.5억 | $85.5억 | $98.6억 | $44.6억 | $59.8억 | $139억 | $115억 | $63.9억 | $85억 | $175억 | $117억 | $88.5억 | |
| 미지급세금 | $29.9억 | $33.2억 | $43.1억 | $48.3억 | $37.7억 | $42.2억 | $16.7억 | $19.3억 | $0 | $10.9억 | $10.5억 | $19.8억 | |
| 기타 유동부채 | $39.9억 | $21.8억 | $28.4억 | $36.2억 | $41.3억 | $25.5억 | $33억 | $39.7억 | $45.3억 | $29.1억 | $9000만 | $0 | |
| 유동부채 | $463억 | $487억 | $539억 | $518억 | $503억 | $569억 | $542억 | $509억 | $541억 | $577억 | $549억 | $555억 | |
| 장기차입금 | $259억 | $251억 | $316억 | $313억 | $307억 | $384억 | $392억 | $394억 | $394억 | $375억 | $373억 | $358억 | |
| 이연법인세부채 | $31.9억 | $31.7억 | $26.4억 | $29.5억 | $24.5억 | $24.3억 | $38억 | $59.9억 | $67.9억 | $70.1억 | $66.1억 | $48.4억 | |
| 기타 비유동부채 | $234억 | $250억 | $213억 | $221억 | $252억 | $179억 | $177억 | $173억 | $173억 | $175억 | $172억 | $198억 | |
| 비유동부채 | $525억 | $532억 | $556억 | $564억 | $583억 | $587억 | $607억 | $627억 | $635억 | $620억 | $612억 | $604억 | |
| 부채총계 | $988억 | $1020억 | $1100억 | $1080억 | $1090억 | $1160억 | $1150억 | $1140억 | $1180억 | $1200억 | $1160억 | $1160억 | |
| 자본 | |||||||||||||
| 보통주 및 주식발행초과금 | $31.2억 | $31.2억 | $31.2억 | $31.2억 | $31.2억 | $31.2억 | $31.2억 | $31.2억 | $31.2억 | $31.2억 | $31.2억 | $31.2억 | |
| 이익잉여금 | $1540억 | $1530억 | $1550억 | $1550억 | $1560억 | $1630억 | $1650억 | $1670억 | $1690억 | $1690억 | $1720억 | $1680억 | |
| 기타포괄손익누계액 | -$125억 | -$108억 | -$113억 | -$125억 | -$117억 | -$117억 | -$143억 | -$152억 | -$149억 | -$148억 | -$140억 | -$138억 | |
| 주주지분 | $688억 | $700억 | $715억 | $702억 | $715억 | $781억 | $785억 | $793억 | $815억 | $812억 | $850억 | $815억 | |
| 부채(차입) | |||||||||||||
| 총차입금(리스 포함) | $293억 | $336억 | $415억 | $358억 | $366억 | $523억 | $508억 | $458억 | $479억 | $550억 | $490억 | $447억 | |
| 순차입금(차입금 - 현금) | $74.7억 | $81.6억 | $166억 | $158억 | $125억 | $138억 | $322억 | $276억 | $282억 | $333억 | $286억 | $277억 | |
| 재무상태표 | 추세 | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 자산 | |||||||||||
| 현금 및 현금성자산 | $190억 | $178억 | $181억 | $173억 | $140억 | $145억 | $129억 | $219억 | $241억 | $197억 | |
| 단기투자 | $229억 | $4.72억 | $15.8억 | $19.8억 | $112억 | $171억 | $93.9억 | $10.7억 | $4.17억 | $3.93억 | |
| 매출채권 | $117억 | $135억 | $141억 | $145억 | $136억 | $190억 | $169억 | $149억 | $189억 | $172억 | |
| 재고자산 | $81.4억 | $87.7억 | $86억 | $90.2억 | $93.4억 | $104억 | $103억 | $112억 | $124억 | $142억 | |
| 기타 유동자산 | $0 | $0 | $9.5억 | $9400만 | $0 | -$37억 | $58.3억 | $0 | $0 | $41.5억 | |
| 유동자산 | $650억 | $431억 | $460억 | $453억 | $512억 | $610억 | $553억 | $535억 | $559억 | $556억 | |
| 유형자산(순액) | $159억 | $170억 | $170억 | $177억 | $188억 | $190억 | $180억 | $199억 | $205억 | $232억 | |
| 영업권 | $228억 | $319억 | $305억 | $336억 | $364억 | $352억 | $360억 | $366억 | $442억 | $488억 | |
| 무형자산 | $269억 | $532억 | $476억 | $476억 | $534억 | $464억 | $385억 | $342억 | $376억 | $504억 | |
| 이연법인세자산 | $61.5억 | $71.1억 | $76.4억 | $78.2억 | $85.3억 | $102억 | $89.5억 | $92.8억 | $105억 | $68.7억 | |
| 기타 비유동자산 | $44.4억 | $49.7억 | $41.8억 | $57억 | $65.6억 | $102억 | $306억 | $142억 | $114억 | $144억 | |
| 비유동자산 | $762억 | $1140억 | $1070억 | $1120억 | $1240억 | $1210억 | $1320억 | $1140억 | $1240억 | $1440억 | |
| 자산총계 | $1410억 | $1570억 | $1530억 | $1580억 | $1750억 | $1820억 | $1870억 | $1680억 | $1800억 | $1990억 | |
| 부채 | |||||||||||
| 매입채무 | $69.2억 | $73.1억 | $75.4억 | $85.4억 | $95.1억 | $111억 | $98.9억 | $96.3억 | $103억 | $120억 | |
| 미지급비용 | $137억 | $175억 | $201억 | $240억 | $255억 | $257억 | $243억 | $262억 | $261억 | $277억 | |
| 단기차입금 | $46.8억 | $39.1억 | $28억 | $12억 | $26.3억 | $37.7억 | $128억 | $34.5억 | $59.8억 | $85억 | |
| 미지급세금 | $9.71억 | $18.5억 | $8.18억 | $22.7억 | $13.9억 | $11.1억 | $22.2억 | $29.9억 | $37.7억 | $0 | |
| 기타 유동부채 | $9.71억 | $18.5억 | $8.18억 | $22.7억 | $34.8억 | $35.9억 | $66.4억 | $39.9억 | $41.3억 | $45.3억 | |
| 유동부채 | $263억 | $305억 | $312억 | $360억 | $425억 | $452억 | $558억 | $463억 | $503억 | $541억 | |
| 장기차입금 | $224억 | $307억 | $277억 | $265억 | $326억 | $300억 | $269억 | $259억 | $307억 | $394억 | |
| 이연법인세부채 | $29.1억 | $83.7억 | $75.1억 | $59.6억 | $72.1억 | $74.9억 | $39.9억 | $31.9억 | $24.5억 | $67.9억 | |
| 기타 비유동부채 | $192억 | $276억 | $268억 | $298억 | $293억 | $253억 | $239억 | $234억 | $252억 | $173억 | |
| 비유동부채 | $445억 | $666억 | $620억 | $623억 | $691억 | $628억 | $548억 | $525억 | $583억 | $635억 | |
| 부채총계 | $708억 | $971억 | $932억 | $983억 | $1120억 | $1080억 | $1110억 | $988억 | $1090억 | $1180억 | |
| 자본 | |||||||||||
| 보통주 및 주식발행초과금 | $31.2억 | $31.2억 | $31.2억 | $31.2억 | $31.2억 | $31.2억 | $31.2억 | $31.2억 | $31.2억 | $31.2억 | |
| 이익잉여금 | $1110억 | $1020억 | $1060억 | $1110억 | $1140억 | $1230억 | $1280억 | $1540억 | $1560억 | $1690억 | |
| 기타포괄손익누계액 | -$149억 | -$132억 | -$152억 | -$159억 | -$152억 | -$131억 | -$130억 | -$125억 | -$117억 | -$149억 | |
| 주주지분 | $704억 | $602억 | $598억 | $595억 | $633억 | $740억 | $768억 | $688억 | $715억 | $815억 | |
| 부채(차입) | |||||||||||
| 총차입금(리스 포함) | $271억 | $346억 | $305억 | $277억 | $353억 | $338억 | $396억 | $293억 | $366억 | $479억 | |
| 순차입금(차입금 - 현금) | $81.5억 | $168억 | $124억 | $104억 | $213억 | $193억 | $268억 | $74.7억 | $125억 | $282억 | |
Financial Modeling Prep이 기업의 제출 서류를 표준화한 데이터입니다. 지출과 비용은 제공처가 보고한 부호를 그대로 유지합니다. 기간에 마우스를 올리면 종료일이 표시됩니다. 금액 단위는 USD.
현금, 투자, 차입금
분기말다른 재무제표
출처
재무제표, 부문 매출, 지표, 추정치: Financial Modeling Prep. 부문별 이익과 전체 보고 항목: SEC EDGAR(XBRL). 참조한 제출 서류: 10-Q 2026-09-27, 10-Q 2026-06-28, 10-Q 2026-03-29, 10-K 2025-12-28, 10-Q 2025-09-28, 10-Q 2025-06-29, 10-Q 2025-03-30, 10-K 2024-12-29, 10-Q 2024-09-29
데이터 기준일 2026-11-01